基于CT的影像组学鉴别不典型无功能胰腺神经内分泌肿瘤与胰腺导管腺癌
研究纳入2014年7月至2017年12月147例患者(胰腺导管腺癌80例、不典型无功能胰腺神经内分泌肿瘤67例),按时间顺序分为原发队列和验证队列,构建影像组学签名模型、临床影像特征模型及二者整合模型。验证队列中整合模型AUC为0.884,显著优于临床影像特征模型(AUC=0.775,P=0.004),与影像组学签名模型(AUC=0.873,P=0.512)相当;整合模型列线图在原发和验证队列的C指数分别为0.960和0.884。
要点
- 整合模型在验证队列鉴别不典型无功能胰腺神经内分泌肿瘤与胰腺导管腺癌的AUC为0.884。
- 整合模型显著优于临床影像特征模型(AUC=0.775,P=0.004)。
- 整合模型与影像组学签名模型性能相当(AUC=0.873,P=0.512)。
核心结论
- 整合模型在鉴别不典型无功能胰腺神经内分泌肿瘤与胰腺导管腺癌方面优于单用临床影像特征模型,与单用影像组学签名模型相当。
- 列线图实现了术前无创的优化鉴别诊断,可更好地为临床治疗选择提供信息。
研究设计与样本
- 研究为诊断模型开发与验证研究,纳入2014年7月至2017年12月连续入组的147例患者(胰腺导管腺癌80例、不典型无功能胰腺神经内分泌肿瘤67例),均有病理结果和增强CT。
- 患者按时间顺序分为原发队列和验证队列,构建影像组学签名模型、临床影像特征模型及整合模型三种模型。
- 在验证队列中以受试者工作特征曲线下面积(AUC)评估并比较三种模型的诊断性能,用列线图表示性能最佳的模型并评估其校准度。
诊断标准与关键数值
- 验证队列中整合模型鉴别诊断的AUC为0.884。
- 验证队列中临床影像特征模型AUC为0.775,整合模型较之显著提高(P=0.004)。
- 验证队列中影像组学签名模型AUC为0.873,整合模型与之相当(P=0.512)。
- 整合模型列线图在原发队列C指数为0.960、验证队列C指数为0.884。
临床应用与阅片要点
- 作者认为,列线图可实现术前无创的不典型胰腺神经内分泌肿瘤与胰腺导管腺癌优化鉴别诊断,从而更好地为临床治疗选择提供信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To develop and validate an effective model to differentiate NF-pNET from PDAC.
MATERIALS AND METHODS: Between July 2014 and December 2017, 147 patients (80 patients with PDAC and 67 patients with atypical NF-pNET) with pathology results and enhanced CT were consecutively enrolled and chronologically divided into primary and validation cohorts. Three models were built to differentiate atypical NF-pNET from PDAC, including a model based on radiomic signature alone, one based on clinicoradiological features alone and one that integrated the two. The diagnostic performance of the three models was estimated and compared with the area under the receiver operating characteristic curve (AUC) in the validation cohort. A nomogram was used to represent the model with the best performance, and the associated calibration was also assessed.
RESULTS: In the validation cohort, the AUC for differential diagnosis was 0.884 with the integrated model, which was significantly improved over that of the model based on clinicoradiological features (AUC = 0.775, p value = 0.004) and was comparable to that of the model based on the radiomic signature (AUC = 0.873, p value = 0.512). The nomogram representing the integrated model achieved good discrimination performances in both the primary and validation cohorts, with C-indices of 0.960 and 0.884, respectively.
CONCLUSION: The integrated model outperformed the model based on clinicoradiological features alone and was comparable to the model based on the radiomic signature alone with respect to the differential diagnosis of atypical NF-pNET and PDAC. The nomogram achieved an optimal preoperative, noninvasive differential diagnosis between atypical pNET and PDAC, which can better inform therapeutic choice in clinical practice.
引用
- He M, Liu Z, Lin Y, et al. Differentiation of atypical non-functional pancreatic neuroendocrine tumor and pancreatic ductal adenocarcinoma using CT based radiomics. Eur J Radiol. 2019. PMID: 31307634. doi:10.1016/j.ejrad.2019.05.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。